Research

[Taiwan Startup Investment Watch] Notable Deals, Jul-Aug 2025

According to the latest data compiled by FINDIT Research Team, eight notable startup funding deals were recorded in Taiwan between July and August 2025. Among them, Syncell (Taiwan) Inc., a biotechnology company developing a proteomics platform, secured the largest funding amount during this period, raising NT$750 million. Highlights from this period are summarized below.

• ArtwayTech Company Limited, operator of the ARTOGO online arts and cultural exhibition streaming platform, completed a NT$15 million strategic funding round. 

• Little Ears Cultural Media Co., Ltd., known for its flagship app “MomDadStory” and focused on audio-based learning and children’s story content, completed a NT$20 million Pre-A round.

• Syncell (Taiwan) Inc., a developer of the world’s first technology platform integrating microscopy to precisely capture proteins and nucleic acids, secured a NT$750 million Series A round.

• Fontrip Technology Co., Ltd., a provider of destination management systems, completed a NT$180 million funding round. 

• Zettabyte Holdings Inc., which is building a one-stop GPU cloud computing platform, received a strategic investment. 

• Alpha Intelligence Manifolds, Inc., focused on AI-enabled medical device software for chronic skeletal and cardiovascular diseases, completed a NT$125 million Pre-A round.

• Astron Medtech Co., Ltd., specializing in orthopaedic sports and foot and ankle medical devices, secured US$2.5 million (approximately NT$76 million) in a Seed+ round. 

• James Tech Consulting Group Co., Ltd., which provides SaaS implementation consulting services and customized development support, completed a Pre-A round exceeding US$1 million.

For more detailed information on the startups featured in this period, please refer to the sections below.

ArtwayTech Company Limited Completes NT$15 Million Strategic Funding Round

Funding News

Founded in 2019, ArtwayTech (ARTOGO) aims to modernize traditional museum audio guide systems through digital art tour solutions. The platform has accumulated more than 600 online exhibitions to date and launched a paid online guided tour service in 2024, with ticket sales exceeding 1,000. The company has also introduced its mobile tour guide brand, “gotour,” which has been adopted by cultural institutions in several countries. More recently, ARTOGO secured multiple overseas contracts for the production of online guided tours.

On July 9, ARTOGO announced the completion of a NT$15 million strategic funding round, jointly invested by udn.com, the digital arm of United Daily News Group, and several angel investors. The proceeds will be allocated to content production, technology development, and the strengthening of cross-platform distribution to accelerate service adoption and international market expansion. As a leading digital content platform, udn.com will leverage its extensive membership ecosystem and platform resources to collaborate with ARTOGO on content co-production and shared distribution channels. For example, selected tour content will be adapted into audiobooks and released on udn.com’s audiobook platform, “Whale Selection,” allowing cultural content to reach wider audiences through more diverse formats.

By integrating content, applications, and channels, ARTOGO seeks to expand the global reach of Taiwan’s digital cultural offerings with the support of its strategic investors. As part of this expansion strategy, Japan has been identified as its primary overseas market, with discussions currently underway with museums in Europe and the United Kingdom.

#ArtGuidedTours #Digitalization #MobileGuides

For related coverage, please visit: https://to.findit.org.tw/7v6q7u 

Little Ears Cultural Media Co., Ltd. Completes NT$20 Million Pre-A Round

Funding News

Little Ears Cultural Media Co., Ltd., the edtech startup operating the children’s audio education brand “MomDadStory,” announced the completion of a NT$20 million Pre-A round on July 18. The round was led by Or Impact Investment, with follow-on participation from the Taiwan Creative Content Agency (TAICCA) through the National Development Fund. Proceeds will be allocated to AI technology upgrades, content library expansion, and overseas market development, including entry into Singapore, Malaysia, and North America. The company aims to establish a leading Chinese-language brand in children’s audio education.

“MomDadStory” adopts an “AI-assisted, human-led” strategy. In response to the rapid development of AI-powered content tools such as NotebookLM, the company plans to allocate 40% of the funding to develop an intelligent book selection engine designed to enhance user experience rather than replace core content creation. Beyond improving recommendation accuracy, the product roadmap also includes a smart dashboard that translates listening data into accessible learning indicators for parents. A prototype of the dashboard is expected to be completed and tested by 2025.

The remaining 60% of the funding will be directed toward content expansion and market development. The company plans to increase the number of stories available on the platform to 2,000 by year-end. In addition to strengthening its consumer-facing business, the team has begun expanding into B2B partnerships in 2025, pursuing strategic collaborations with brand partners. Market research and content localization are expected to be completed this year, with formal overseas expansion scheduled for the following year.

#AI #ChildrenLearning #Apps #Podcast

For related coverage, please visit: https://to.findit.org.tw/7x4py3

Syncell (Taiwan) Inc. Completes NT$750 Million Series A Round

Funding News

Syncell (Taiwan) Inc., a Taiwanese biotech instrumentation company, announced on July 23 the completion of a NT$750 million Series A round. The round was led by Taiwania Capital, with participation from Everbright Biofund, the National Development Fund, the ABICO Group, Himalaya Venture Fund, Ta Ya Venture Capital, BE Health, Isaiah Capital, Hua Nan Venture Capital, First Venture Capital, Tong An Investment, ITRI’s Industrial Technology Investment Corporation, and IBT Venture Capital.

Syncell’s core product, “Microscoop,” is built on proprietary patented technology that enables the precise identification of previously unknown disease-related proteins in clinical samples. It is designed to support early-stage biomarker discovery and accelerate new drug development. It has been adopted by leading international medical institutions, including the Mayo Clinic in the United States. The company serves clients across North America, Europe, and Asia, and its international sales network continues to expand. 

Proceeds from the round will be allocated to technology development and international market expansion. Looking ahead, Syncell plans to further strengthen its presence in North America and Europe, expand production capacity, and broaden its application scope. The company aims to become a key global supplier of instrumentation for disease detection and drug development, while serving as a model for the international expansion of Taiwan’s biotechnology industry.

#Biotechnology #DiseaseDetection #DrugDevelopment #BiotechInstrumentation

For related coverage, please visit: https://to.findit.org.tw/7xmbds 

Fontrip Technology Co., Ltd. Completes NT$180 Million Funding Round

Funding News

Fontrip Technology Co., Ltd. announced on July 29 the completion of a NT$180 million funding round. The round was led by CDIB Capital’s Hsin Yueh Development Fund, with participation from Top Taiwan Venture Capital and the Golden Asia Fund, as well as follow-on investment from existing shareholders Lion Travel and Klook. 

Incubated by the Industrial Technology Research Institute (ITRI) and invested by Lion Travel, Fontrip is a digital ticketing platform provider and destination management system (DMS) developer, offering integrated solutions spanning ticketing, experiential products, distribution channels, and data management. The company currently holds approximately 80% of Taiwan’s digital travel package market and partners with more than 1,000 attractions, including the National Palace Museum, Taipei 101, Sun Moon Lake, and Alishan. Its platform connects with over 60 domestic and international distribution channels.

In recent years, Fontrip has expanded its overseas operations by extending its Taiwan-proven model to Okinawa. Through its integrated City Pass and bus e-ticket solution, the company has demonstrated commercial viability in the local market. Looking ahead, Fontrip views Asia’s tourism industry as undergoing transformation driven by digitalization, cashless travel, and smart venue development. Building on its experience in Okinawa, the company plans to expand into Kyushu, Hokkaido, and Hong Kong, while also evaluating opportunities in South Korea and Southeast Asia to broaden its regional footprint.

Alongside its international expansion, Fontrip continues to strengthen its system capabilities through ongoing technology upgrades and the introduction of AI applications to improve multilingual customer service efficiency and issue resolution. By integrating diverse data sources, the company aims to generate deeper user insights and further optimize its product offerings. Proceeds from the round will accelerate its international expansion and technological innovation, advancing its global smart tourism ecosystem strategy. The new investors, with extensive experience in supporting technology startups and international expansion, are expected to contribute strategic resources and global network support.

#Tourism #DigitalTravelPass #Apps #SaaS

For related coverage, please visit: https://to.findit.org.tw/7y3huu

Zettabyte Holdings, Inc. Receives Strategic Investment

Funding News

Zettabyte Holdings, Inc. announced on August 5 the completion of a strategic investment from Lam Capital, the venture capital subsidiary of U.S.-based semiconductor equipment manufacturer Lam Research. The round also saw participation from leading Taiwanese technology companies, including Foxconn, Pegatron, and Wistron, reflecting investor confidence in the company’s growth prospects.

Zettabyte provides AI data center construction and infrastructure solutions and is developing a one-stop GPU cloud computing platform that enables enterprises to build secure, scalable, and high-performance computing environments. Its proprietary Zware platform integrates the high-speed networking, cluster management, and liquid cooling systems required for AI workloads, improving energy efficiency and strengthening overall cybersecurity. As generative AI drives increasing computational demands, Zettabyte has further enhanced its AI chip integration expertise, reinforcing hardware-software coordination and accelerating the deployment of high-performance AI systems.

The proceeds will accelerate global expansion and advance the development of its Zsuite platform. Designed for Infrastructure-as-a-Service (IaaS) environments with end-to-end optimization, Zsuite aims to help enterprises and government agencies reduce total cost of ownership. The platform supports heterogeneous computing architectures and flexible AI chip scheduling, enhancing computing performance and improving infrastructure utilization. With Lam Capital as a strategic partner, Zettabyte is expected to further strengthen its expertise in performance optimization, energy efficiency, cybersecurity, and AI chip and semiconductor integration.

#AI #DataCenterInfrastructure #CloudComputingPlatform #IaaS

For related coverage, please visit: https://to.findit.org.tw/7z5al2 

Alpha Intelligence Manifolds, Inc. Completes NT$125 Million Pre-A Round

Funding News

Alpha Intelligence Manifolds, Inc. announced on August 19 the completion of a NT$125 million Pre-A round. The round was co-led by WI Harper Group and BE Health, with participation from Cathay Venture, the National Development Fund, and Sustainable Impact Capital (SIC). 

Alpha Intelligence Manifolds is a Taiwan-based AI medical startup applying AI-powered imaging technology to support clinicians in the early detection of chronic diseases. The company currently focuses on high-prevalence conditions, including cardiovascular disease and osteoporosis. Its AI imaging models have achieved accuracy rates exceeding 95%, with diagnostic interpretation completed in as little as 30 seconds. The company’s product portfolio comprises three core applications: DeepPACS, an underlying AI imaging platform that supports a broad range of medical image analysis; DeepXray, designed for X-ray examinations to assist in diagnosing skeletal conditions such as osteoarthritis and osteoporosis; and DeepSono, used in cardiac ultrasound examinations to support the detection of cardiovascular conditions, including chronic heart failure.

The proceeds will accelerate regulatory certification, expand global patent coverage, and advance market development for DeepXray and DeepSono in key markets including Japan, Vietnam, Thailand, and Malaysia, while also supporting next-generation product development. In particular, DeepSono, which focuses on cardiac ultrasound diagnostics, is expected to expand into broader clinical scenarios, including health screening, clinical practice, long-term care, emergency care, and oncology treatment, enabling more comprehensive cardiac function assessment. The company also plans to develop integrated hardware-software solutions for home-based care to enhance accessibility and convenience in chronic disease management.

#AIMedicalImaging #Healthcare #XrayImaging #CardiacUltrasound

For related coverage, please visit: https://to.findit.org.tw/82k4pm 

Astron Medtech Co., Ltd. Completes US$2.5 Million Seed+ Round

Funding News

Astron Medtech Co., Ltd announced on August 25 the completion of a US$2.5 million (approximately NT$76 million) Seed+ round. The round was led by Next Level Investment, an angel investment group formed by U.S.-based physicians and distributors, with participation from 36 Capital and other investors.

Astron Medtech’s patented product, the TendMINTM Telescoping Needle and Grasper System, enables surgeons to perform Achilles tendon repair through a minimally invasive incision of approximately one centimeter, improving surgical efficiency and reducing postoperative recovery time. The system underwent market trials in the United States from February to June 2022, during which the company established a U.S. subsidiary. In March 2025, the TendMINTM system received marketing clearance from the U.S. Food and Drug Administration (FDA).

The proceeds will be allocated to high-density, well-insured metropolitan markets, including Florida, Chicago, New York, and Boston. By establishing partnerships with leading foot and ankle specialists and surgical centers, Astron Medtech aims to expand its market presence in the United States. On the product front, the company plans to begin mass production of its newly developed TendMINTM ultrasound minimally invasive surgical system. It will also invest in training platforms and AI software development to improve the accuracy of ultrasound-guided procedures, thereby strengthening clinical applicability. Beyond capital support, the investors contribute extensive industry experience and market resources. In particular, the network of U.S. physicians and distributors represented by Next Level Investment is expected to serve as a key driver of Astron Medtech’s rapid expansion in the U.S. market.

#MedicalDevices #UltrasoundMinimallyInvasiveSurgery #Healthcare

For related coverage, please visit: https://to.findit.org.tw/836xjd 

James Tech Consulting Group Co., Ltd. Completes Pre-A Round Exceeding US$1 Million

Funding News

James Tech Consulting Group Co., Ltd. announced on August 28 the completion of a Pre-A round exceeding US$1 million. The round was led by AppWorks. 

James Tech became an authorized agent of Zendesk, a global leader in customer service platforms, in its early years. As generative AI tools such as ChatGPT gained traction, major international vendors began introducing proprietary AI features. However, limitations in localization and pricing flexibility reduced the effectiveness of these solutions in Asian markets. In 2023, James Tech launched its customer service chatbot, Raccoon AI, in response to this market gap, addressing common challenges faced by mid-sized and large enterprises during CRM system transitions, including high switching costs, data migration risks, and prolonged employee training periods. To date, Raccoon AI has secured more than 30 mid-sized and large paying clients across sectors such as e-commerce, software services, retail, and real estate. For example, VERVE, a performance apparel brand, reported that following implementation, nearly 90% of frontline customer inquiries are now handled directly by AI, with average response times reduced from more than one day to approximately three to five minutes.

The proceeds will support two strategic priorities. First, the company plans to expand into overseas markets in the second half of 2025, targeting Japan and South Korea, where labor costs are relatively high. According to James Tech, the company does not intend to engage directly with end customers in these markets. Instead, it will collaborate with Zendesk’s local agents, leveraging established partner networks to introduce its solutions to enterprises with relevant demand and replicate its Taiwan-proven model. Second, on the product development front, the company plans to recruit additional senior engineers and is scheduled to launch a voice input feature in October to further enhance the customer service experience and strengthen its technological advantages.

#CustomerServiceChatbot #AI #SaaS #CRM

For related coverage, please visit: https://to.findit.org.tw/83r5wn